IT1245717B - Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche - Google Patents

Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche

Info

Publication number
IT1245717B
IT1245717B IT02096890A IT2096890A IT1245717B IT 1245717 B IT1245717 B IT 1245717B IT 02096890 A IT02096890 A IT 02096890A IT 2096890 A IT2096890 A IT 2096890A IT 1245717 B IT1245717 B IT 1245717B
Authority
IT
Italy
Prior art keywords
treatment
delphidin
pelargonidin
antocyanidine
compound based
Prior art date
Application number
IT02096890A
Other languages
English (en)
Other versions
IT9020968A0 (it
IT9020968A1 (it
Inventor
Maria Jose Magistretti
Marisa Conti
Giorgio Pifferi
Original Assignee
Idb Holding Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idb Holding Spa filed Critical Idb Holding Spa
Publication of IT9020968A0 publication Critical patent/IT9020968A0/it
Publication of IT9020968A1 publication Critical patent/IT9020968A1/it
Application granted granted Critical
Publication of IT1245717B publication Critical patent/IT1245717B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
IT02096890A 1989-07-28 1990-07-18 Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche IT1245717B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898917323A GB8917323D0 (en) 1989-07-28 1989-07-28 Methods and pharmaceutical compositions for the treatment of ophthalmic diseases

Publications (3)

Publication Number Publication Date
IT9020968A0 IT9020968A0 (it) 1990-07-18
IT9020968A1 IT9020968A1 (it) 1992-01-18
IT1245717B true IT1245717B (it) 1994-10-14

Family

ID=10660801

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02096890A IT1245717B (it) 1989-07-28 1990-07-18 Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche

Country Status (11)

Country Link
US (1) US5196449A (it)
EP (1) EP0410749B1 (it)
JP (1) JP2967523B2 (it)
KR (1) KR0149026B1 (it)
AT (1) ATE112960T1 (it)
DE (1) DE69013431T2 (it)
DK (1) DK0410749T3 (it)
GB (1) GB8917323D0 (it)
HK (1) HK124595A (it)
IT (1) IT1245717B (it)
PT (1) PT94848A (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673513B1 (fr) * 1991-03-05 1993-10-29 Institut Recherche Biologique Sa Nouvelles compositions dietetiques a base de lipides phosphoryles et leur utilisation dans l'amelioration des troubles de la vision.
JP3414446B2 (ja) * 1993-07-23 2003-06-09 財団法人相模中央化学研究所 ヒドロキシシリル基を末端に有するポリオキシエチレン化合物、四級塩を末端に有するブロック共重合体、および経皮吸収促進剤
JPH1059846A (ja) * 1996-06-10 1998-03-03 Kikkoman Corp 白内障の予防または治療薬剤
ES2303509T3 (es) * 1999-07-02 2008-08-16 Meiji Seika Kaisha, Ltd. Composiciones para alimentos, proceso para su produccion y alimentos y bebidas funcionales que las contienen.
FR2811550B1 (fr) * 2000-07-11 2003-02-14 Oreal Composition a base de vitamines et de sels mineraux, pour diminuer la chute des cheveux et/ou favoriser la repousse des cheveux
US7014991B2 (en) * 2001-11-16 2006-03-21 Infinite Vision, Llc Use of injectable dyes for staining an anterior lens capsule and vitreo-retinal interface
EP1681297A4 (en) 2003-10-30 2009-06-17 Meiji Seika Kaisha INHIBITOR OF TYROSINASE ACTIVITY AND MEANS TO IMPROVE THE BLOOD OF THE FACE
JP4873904B2 (ja) * 2005-08-22 2012-02-08 国立大学法人弘前大学 眼血管血流障害改善剤
FR2975008B1 (fr) * 2011-05-13 2014-03-07 Inst Biophytis Utilisation de composes et composition pour le traitement de la degenerescence maculaire liee a l'age (dmla)
JP2013163669A (ja) * 2012-01-12 2013-08-22 Oriza Yuka Kk 可視光誘発網膜障害抑制剤及びそれを用いた眼疾患予防・治療剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1589294A (en) * 1976-09-08 1981-05-13 Inverni Della Beffa Spa Pharmaceutical compositions containing anthocyanidines
FR2378272A1 (fr) * 1977-01-25 1978-08-18 Ferodo Sa Dispositif dynamometrique de mesure de couple pour engin a fleche de levage a commande par verin
BE864450R (fr) * 1978-03-01 1978-07-03 Inverni Della Beffa Spa Compositions pharmaceutiques a base d'anthocyanidine, leur preparation et leur utilisation
FR2461499A1 (fr) 1979-07-23 1981-02-06 Inverni Della Beffa Spa Composition pharmaceutique a base d'extraits de myrtille
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
DE3670570D1 (de) * 1986-09-02 1990-05-31 Alcon Lab Inc Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom.

Also Published As

Publication number Publication date
DE69013431D1 (de) 1994-11-24
DK0410749T3 (da) 1994-11-14
KR0149026B1 (ko) 1998-10-15
GB8917323D0 (en) 1989-09-13
US5196449A (en) 1993-03-23
IT9020968A0 (it) 1990-07-18
EP0410749A3 (en) 1993-02-03
HK124595A (en) 1995-08-11
JPH0381220A (ja) 1991-04-05
EP0410749A2 (en) 1991-01-30
ATE112960T1 (de) 1994-11-15
KR910002442A (ko) 1991-02-25
EP0410749B1 (en) 1994-10-19
IT9020968A1 (it) 1992-01-18
PT94848A (pt) 1991-04-18
JP2967523B2 (ja) 1999-10-25
DE69013431T2 (de) 1995-02-23

Similar Documents

Publication Publication Date Title
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
DE69939705D1 (de) Behandlung der pompeschen krankheit
AU549481B2 (en) Hair growing agent
NO912410L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklen-derivater.
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
EP0249735A3 (en) Pharmaceutical preparations comprising as active agent 2-phenyl-1.2-benzisoselenazol-3(2h)-one, for the treatment of diseases caused by oxidative stress
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
EP0444196A4 (en) Agent for treatment and prophylaxis of ischemic disease of heart or brain
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
NO902800D0 (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
IT1245717B (it) Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche
DK0412554T3 (da) Sustained-release-præparat til administration i hjernen
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
SE8200748L (sv) Terapeutiskt medel
GR3017672T3 (en) Therapeutic agent for diabetic gangrene.
BG96092A (bg) Тиенотиопиранови сулфонамидни производни и приложението им в офталмологични препарати

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970728